Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan L Moore

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2023
Reply to R. Sun et alJonathan L Moore, Aida Santaolalla, Mieke Van Hemelrijck, et al.
European Radiology|March 15, 2023
Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinomaJonathan L Moore, Manil Subesinghe, Aida Santaolalla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 11, 2022
Patient perspectives on key symptoms and preferences for follow-up after upper gastro-intestinal cancer surgeryPhilip H Pucher, Annie Coombes, Orla Evans, et al.
European Journal of Cancer (Oxford, England : 1990)|January 27, 2022
Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago-gastric adenocarcinoma - A comparison of the FLOT and 'MAGIC' regimensJonathan L Moore, Sacheen Kumar, Aida Santaolalla, et al.
The British Journal of Surgery|August 23, 2023
Prehabilitation exercise before oesophagectomy: long-term follow-up of patients declining/withdrawing from the programWilliam Knight, Jonathan L Moore, Greg P Whyte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2023
Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United KingdomJonathan L Moore, Michael Green, Aida Santaolalla, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2023
Reply to R. Sun et alJonathan L Moore, Aida Santaolalla, Mieke Van Hemelrijck, et al.
European Radiology|March 15, 2023
Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinomaJonathan L Moore, Manil Subesinghe, Aida Santaolalla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 11, 2022
Patient perspectives on key symptoms and preferences for follow-up after upper gastro-intestinal cancer surgeryPhilip H Pucher, Annie Coombes, Orla Evans, et al.
European Journal of Cancer (Oxford, England : 1990)|January 27, 2022
Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago-gastric adenocarcinoma - A comparison of the FLOT and 'MAGIC' regimensJonathan L Moore, Sacheen Kumar, Aida Santaolalla, et al.
The British Journal of Surgery|August 23, 2023
Prehabilitation exercise before oesophagectomy: long-term follow-up of patients declining/withdrawing from the programWilliam Knight, Jonathan L Moore, Greg P Whyte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2023
Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United KingdomJonathan L Moore, Michael Green, Aida Santaolalla, et al.
Pageof 1